Bill: HCR 86, 87(R) - 2021

Committee

House Public Health

2nd Chamber Committee

Senate Health and Human Services

Vote Recommendation

Vote Recommendation Economic Freedom Property Rights Personal Responsibility Limited Government Individual Liberty
Vote No; Amend Negative Neutral Neutral Negative Neutral

Author(s)

Jarvis Johnson

Sponsor(s)

Borris Miles

Bill Caption

Expressing support for equitable access to transformative therapies for sickle cell disease.     

Bill Analysis

HCR 86 would resolve to support the equitable access to transformative therapies for sickle cell disease. 

Vote Recommendation Notes

Texas Action opposes HCR 86 unless amended to replace the word "equitable" with the word "equal".

Equality allows the same access for everyone without discrimination. Equity promotes levelized outcomes for various groups which implicitly requires discrimination against some groups to the benefit of others. Public policy in this state should always prioritize equality, not equity. HCR 86 should be amended to promote equality, not equity.


Source URL (retrieved on 08/18/2025 04:08 PM): http://reports.texasaction.com/bill/87r/hcr86?print_view=true